Imodium Instant

Loperamide Hydrochloride, the active ingredient in Imodium Instant, is an opioid antidiarrheal presented as an oral formulation for oral use. It treats acute diarrhea and travelers' diarrhea in adults and children.

GNH USA supplies Imodium Instant as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Imodium Instant (loperamide) is used to manage conditions involving increased intestinal motility.

Acute diarrhea: reduces stool frequency and improves consistency in sudden‑onset loose stools. Travelers' diarrhea: provides symptomatic relief of loose stools during short‑term travel exposures. Gastroenteritis‑related diarrhea: helps control watery stools associated with viral or bacterial gastroenteritis.

Loperamide may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Abdominal cramps or discomfort - Constipation or hard stools - Nausea or mild vomiting - Dry mouth - Dizziness or light‑headedness - Drowsiness or fatigue

Serious or Rare Side Effects: - Severe constipation or bowel obstruction (ileus) - Toxic megacolon, especially in patients with underlying infection - Allergic reactions such as rash, itching, or swelling - Cardiac arrhythmias (QT prolongation) with high plasma levels - Severe skin reactions (Stevens‑Johnson syndrome, toxic epidermal necrolysis) - Central nervous system depression in overdose situations

When using Imodium Instant, consider the following safety measures.

Do not exceed recommended dose: follow prescriber or label instructions. Use caution in hepatic impairment: reduced metabolism may increase drug levels. Avoid in children under 2 years: risk of serious side effects outweighs benefit. Medical supervision for bacterial infection: may prolong pathogen carriage. Monitor for signs of constipation: discontinue if severe constipation develops. Store at room temperature: keep in the original pack, protect from moisture.

Loperamide can interact with other medicines; be aware of the following.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may raise loperamide plasma concentrations. - Concurrent opioid agonists: additive central opioid effects can increase sedation. - Quinidine or other QT‑prolonging agents: heightened risk of cardiac arrhythmia.

Moderate Interactions (Monitor Closely): - Anticholinergic drugs: may exacerbate constipation. - Sedatives or antihistamines: can enhance drowsiness. - Rifampin or other CYP3A4 inducers: may reduce loperamide effectiveness.